# Efficacy and Safety of YAM80 in Amyotrophic Lateral Sclerosis (ALS)

> **NCT00886977** · PHASE2 · UNKNOWN · sponsor: **Yoshino Neurology Clinic** · enrollment: 25 (estimated)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** YAM80

## Key facts

- **NCT ID:** NCT00886977
- **Lead sponsor:** Yoshino Neurology Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-04
- **Primary completion:** 2010-12
- **Final completion:** —
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2010-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00886977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00886977, "Efficacy and Safety of YAM80 in Amyotrophic Lateral Sclerosis (ALS)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00886977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*